< Back to latest news & events

News

More Exam Success!

July 2023

HGF is pleased to announce more success for many of our colleagues in the recent exams on becoming qualified attorneys and would like to congratulate them on this fantastic achievement.

Martyn Fish, CEO commented on how “delighted” he is about the recent European exam results, saying “These exams are tough and the experience of going through them can be even tougher so huge congratulations are in order. Enjoy and savor the moment!”

In no specific order, we would like to say well done and a huge congratulations to the following people:

Who are now all dual (UK and European) qualified.

  • David Kim – who is now dual (Korean and European) qualified.

Who are now all European qualified

The firm would also like to take this opportunity to thank our tutors and mentors for their contribution in helping others prepare for the exams and ultimately help colleagues progress.

Tutors:

Mentors

Martyn Fish, CEO commented: “You have all given time to help others prepare and ultimately progress their careers. Thank you!”

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article